<italic toggle="yes">In Silico</italic> Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations

<italic toggle="yes">In Silico</italic> Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations

ABSTRACT The membrane-anchored spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a pivotal role in directing the fusion of the virus particle mediated by the host cell receptor angiotensin-converting enzyme 2 (ACE-2). The fusion peptide region of the S protein S2...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nishant Shekhar, Phulen Sarma, Manisha Prajapat, Pramod Avti, Hardeep Kaur, Anupam Raja, Harvinder Singh, Anusuya Bhattacharya, Saurabh Sharma, Subodh Kumar, Ajay Prakash, Bikash Medhi
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2020
Materias:
severe acute respiratory syndrome coronavirus 2
fusion peptide
molecular dynamics simulation
molecular mechanics/generalized Born model and solvent accessibility
S2 fusion peptide-containing domain
coronavirus
Microbiology
QR1-502
Acceso en línea:https://doaj.org/article/fc81ab84c980417386b1d92ad1e80a48
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/fc81ab84c980417386b1d92ad1e80a48

Ejemplares similares